Platelet Function, Platelet Size and Content of Reticulated Platelets: Interactions in Patients Receiving Dual...

Area of Science:

• Cardiovascular Medicine
• Hematology
• Clinical Biochemistry

Background:

• Increased platelet activity is a significant risk factor for thrombotic events in patients with cardiovascular diseases.
• Understanding factors influencing platelet function is crucial for optimizing antiplatelet therapy.

Purpose of the Study:

• To investigate the relationship between platelet function, platelet size, and reticulated platelet (RP) content in patients with coronary heart disease (CHD) and acute coronary syndrome (ACS).
• To assess how these factors are affected by antiplatelet therapy (acetylsalicylic acid + clopidogrel or ticagrelor).

Main Methods:

• Evaluated platelet function via activated glycoprotein (GP) IIb-IIIa and P-selectin exposure.
• Assessed platelet size using mean volume, % large forms, and forward scattering.
• Quantified reticulated platelets (RP) using thiazole orange staining in control and CHD/ACS patient groups.

Main Results:

• In controls, activated GP IIb-IIIa and P-selectin correlated with platelet size and RP content.
• These correlations were largely maintained in CHD/ACS patients despite reduced platelet activity due to antiplatelet drugs.
• Specifically, activated GP IIb-IIIa showed persistent correlations with platelet size and RP content.

Conclusions:

• Elevated platelet size and RP content are associated with heightened platelet activity.
• These factors may indicate reduced efficacy of standard antiplatelet therapies in certain patient populations.
• Platelet size and RP content serve as potential biomarkers for assessing antiplatelet therapy response.